ADVANZ PHARMA GENERICS (UK) LIMITED

PaymentCheck Score 2024
67Fair
New Entry
#3128 in UK
#38 in Life Sciences And Medical Technology
#1285 in London

Company Information

Company Number
02760679
Registered Address
Dashwood House, 69 Old Broad Street, London, United Kingdom, EC2M 1QS
Status
Active
Employee Count
Coming Soon
Turnover
£45,062,000
EBITDA
£1,347,000

Additional Details

Company Type
Private limited Company
Incorporated On
30 October 1992
Nature of Business
21200 - Manufacture of pharmaceutical preparations
Industries
Life Sciences And Medical Technology
Region
London

Time to Pay

Average Time to Pay
28 days
Shortest Period:45 days
Longest Period:180 days
Max Contractual:180 days

Payment Timeline

Within 30 Days
57%
31-60 Days
43%
After 60 Days
0%
Not Paid Within Terms1%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Company Review

Trend Analysis

ADVANZ PHARMA GENERICS (UK) LIMITED exhibits a prompt average payment time of 28 days, indicating a strong tendency towards timely settlements. A significant majority, 57% of invoices, are paid within 30 days, establishing a consistent pattern of quick processing. While 43% of payments extend into the 31-60 day bracket, there is no trajectory towards excessive delays, as 0% of payments exceed 60 days.

Volatility Analysis

Payment reliability is high, with no instances of payments exceeding 60 days and a minimal late payment rate of only 1%. Suppliers can predict a primary payment window, with 57% paid within 30 days and the remainder (43%) within 31-60 days. This distribution suggests a predictable, albeit sometimes extended, payment cycle, mitigating significant risk of unpredictably long delays.

Summary Analysis

ADVANZ PHARMA GENERICS presents a low payment risk profile for suppliers, characterized by an average 28-day payment time and a very low 1% late payment rate. Key decision factors for suppliers should be the high certainty of payment within 60 days and the strong likelihood of receiving payment within 30 days. No specific risk mitigation strategies for extreme payment default appear necessary based on this data, though aligning terms to account for the 30-60 day possibility is prudent.

Performance Reports History

Reporting Period Filed: 2025-01-29
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2024 - 31 Dec 202429 Jan 20252857%43%0%1%
01 Jan 2024 - 30 Jun 202429 Jul 2024494%84%12%2%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice" The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month" There have been no changes to the company standard terms during the reporting period.

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

NA

Maximum contractual payment period agreed

180

Dispute Resolution Process

a) In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c) For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

ADVANZ PHARMA GENERICS (UK) LIMITED is an active private limited company operating within the pharmaceutical generics sector in the United Kingdom. Its company name indicates a specialisation in the development, manufacturing, and supply of generic pharmaceutical products.

The company was incorporated on 30 October 1992 and holds the company number 02760679. Its registered office is situated at Dashwood House, 69 Old Broad Street, London, United Kingdom, EC2M 1QS.

Companies of this type in the UK typically focus on producing and distributing medicines that are bioequivalent to branded drugs after their patents expire. This includes the marketing and supply of more affordable generic versions of established medications to healthcare providers and pharmacies across the UK market.

Financial Metrics

Cash
£1,300
Net Worth
£11,800
Total Current Assets
£22,600
Total Current Liabilities
£10,800

Company Location